SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin jumps on reporting over four-fold rise in Q1 net

25 Jul 2012 Evaluate

Lupin is currently trading at Rs. 586.10, up by 3.95 points or 0.68% from its previous closing of Rs. 582.15 on the BSE.

The scrip opened at Rs. 590.75 and has touched a high and low of Rs. 593.85 and Rs. 580.00 respectively. So far 40,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 593.85 on 24-Jul-2012 and a 52 week low of Rs. 409.50 on 14-Dec-2011.

Last one week high and low of the scrip stood at Rs. 593.85 and Rs. 563.20 respectively. The current market cap of the company is Rs. 26,180 crore.

The promoters holding in the company stood at 46.91% while Institutions and Non-Institutions held 43.97% and 9.12% respectively.

On standalone basis, the company has posted a rise of 391.04% in its net profit at Rs 357.23 crore for the quarter ended June 30, 2012 as compared to Rs 72.75 crore for the same quarter in the previous year. Total income has increased by 61.01% at Rs 1780.29 crore for quarter under review as compared to Rs 1105.71 crore for the quarter ended June 30, 2011.

On consolidated basis, the company has posted a rise of 33.47% in its net profit at Rs 280.39 crore for the quarter ended June 30, 2012 as compared to Rs 210.08 crore for the same quarter in the previous year. Total income has increased by 43.78% at Rs 2253.74 crore for quarter under review as compared to Rs 1567.53 crore for the quarter ended June 30, 2011.

Lupin Share Price

2296.10 -44.10 (-1.88%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×